AMG 900 functions as a potent, orally bioavailable small molecule inhibitor targeting the Janus kinase (JAK) family, specifically JAK1 and JAK2, to modulate cytokine signaling pathways in the treatment… Read more
AMG 900 functions as a potent, orally bioavailable small molecule inhibitor targeting the Janus kinase (JAK) family, specifically JAK1 and JAK2, to modulate cytokine signaling pathways in the treatment of autoimmune conditions like rheumatoid arthritis and myelofibrosis. This category provides essential pharmaceutical reference standards required for rigorous analytical testing, method validation, and quality control of this active pharmaceutical ingredient. Laboratories utilize AMG 900 hydrochloride as a primary reference material for assay standardization, while the deuterated stable isotope labelled compound, AMG 900-d4, serves as an internal standard for precise quantification in complex biological matrices and metabolic stability studies. Additionally, the inclusion of process-related impurities such as N-nitroso AMG 900 enables accurate impurity profiling and risk assessment, ensuring the safety and regulatory compliance of drug product batches during development and manufacturing.